PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are...

Full description

Saved in:
Bibliographic Details
Main Authors MCNEVIN, Michael, LOHANI, Sachin
Format Patent
LanguageEnglish
French
German
Published 01.03.2017
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.
AbstractList The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.
Author LOHANI, Sachin
MCNEVIN, Michael
Author_xml – fullname: MCNEVIN, Michael
– fullname: LOHANI, Sachin
BookMark eNrjYmDJy89L5WQwDfBwDPJ1dHYNDfF0dvRRCHb0CQlW8HdTcPRT8A9yjfD0UwhydXYNCPEPAgqFOLr7-3kGh_AwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAGNDYxMDSyNHQ2MilAAApIspDQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate SELS PHARMACEUTIQUES D'UN ANTAGONISTE DES RÉCEPTEURS DE L'OREXINE
PHARMAZEUTISCHE SALZE EINES OREXINREZEPTORANTAGONISTEN
ExternalDocumentID EP3134092A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3134092A13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:47:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3134092A13
Notes Application Number: EP20150782608
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170301&DB=EPODOC&CC=EP&NR=3134092A1
ParticipantIDs epo_espacenet_EP3134092A1
PublicationCentury 2000
PublicationDate 20170301
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 20170301
  day: 01
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies Merck Sharp & Dohme Corp
RelatedCompanies_xml – name: Merck Sharp & Dohme Corp
Score 3.0783896
Snippet The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170301&DB=EPODOC&locale=&CC=EP&NR=3134092A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgYAbDBDjpRxQbxXrI5t6qFCXpmyIPtRmqLdpfUm7dBMr4u_jlG1wgVvkSE5ixbYc218AHujIpBWafRW980A19bxQLSMv1cK09AwvtU7bRmE_GE5m5ktK0w4sd70wLU7oZwuOiBqVo743rb1e_zxiuW1t5eYxWyJp9eQJ21W20bEm76-muGObR6EbMoUxHClBbBuagZGM7mCgdCBRtyTMPn8by6aU9W-P4p3CYYTM6uYMOmXdg2O2-3itB0f-Nt-Nw63qbc6BRhMn9h3GZ0JCGJDEeRUJCT3iBCSMeToNSMwZj0QYI0k4z2EwTcQFEI8LNlFx_fn-rHMe7XdqXEK3XtXlFRBrZFV5nmeWfHPQ9GxRFWYxkIkNuhjRivah_yeb63_mbuBECu27puoWus37R3mHTrbJ7lvxfAEW1nro
link.rule.ids 230,308,780,885,25564,76547
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR27TsMw8FQVBGxQQJSnB5QtonmYKEOFUschheah1EXdquYldUkrGsTvcw5tYYHNsqWzfbqH73wPgHtqmbREsa-idu6ppp7lqm1khZqbtp4iUeu0SRQOwkd_Yr5M6bQFi20uTFMn9LMpjogclSG_1428Xv04sdwmtnL9kC5wavnkib6rbKxjTdKvpriDPo8jN2IKYzhSwqRvaAZaMrqDhtKeJRvuypfT20Ampax-axTvGPZjBFbVJ9Aqqg4csm3jtQ4cBJv_bhxuWG99CjT2nSRwGJ8IWcKAjJ2RGJPII05IooRPhyFJOOOxiBKcEs5zFA7H4gyIxwXzVdx_trvrjMe7kxrn0K6WVXEBxLbsMsuy1JY-B01P52Vu5j35sUHnFi1pF7p_grn8Z-0ODn0RjGajYfh6BUcSgd_xVdfQrt8_ihtUuHV626DqCwNhfdk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+SALTS+OF+AN+OREXIN+RECEPTOR+ANTAGONIST&rft.inventor=MCNEVIN%2C+Michael&rft.inventor=LOHANI%2C+Sachin&rft.date=2017-03-01&rft.externalDBID=A1&rft.externalDocID=EP3134092A1